Senisca
Splicing Factors for Cell Rejuvenation
Senisca
BioTech
|
Exeter, UK
About
SENISCA develops therapeutics that target splicing regulation decline in ageing. Its approach aims to reverse cellular senescence and rejuvenate cells to address ageing and ageing-related diseases.
Founders
Co-Investors
Longevitytech.fund, R42 Group, University of Exeter
